The best starting point for an Edinburgh or Glasgow fundraise is not the longest investor list. It is a shortlist matched to your company’s stage, Scottish connection and next milestone. This guide compares 16 capital providers, from first-cheque investors and university funds to angel syndicates, public co-investors and established-company growth capital.
Edinburgh and Glasgow sit within a connected Scottish funding ecosystem, but an office address does not establish investment eligibility. Some providers require Scottish operations or registration. Others invest across the UK or Europe. A university fund may require a university connection, while a public co-investor may need a private lead already in place.
Use the stage filters first, then read the restrictions. The list is not a ranking or an endorsement, and inclusion does not mean a provider is right for every Scottish startup.
Compare the Scottish funding routes
| Provider | Capital type and stage | Geographic or eligibility boundary | Public starting point |
|---|---|---|---|
| Archangels | Angel syndicate; proof of concept through Series A | Registered and operationally based in Scotland; B2B technology or life sciences | Investment enquiry |
| Gabriel | Angel syndicate; pre-seed | Scottish-based founders; specialist knowledge or patentable technology | Eligibility information |
| Techstart Ventures | Venture investor; inception to pre-seed | Scotland and Northern Ireland, with separate routes | Scotland investment form |
| Old College Capital | University venture fund; pre-seed to Series A | Ideas and technology emerging from the University of Edinburgh | Edinburgh Innovations |
| Investing Women Angels | Angel syndicate; pre-seed and seed | UK-based company with at least one female founder | Dealum application |
| Equity Gap | Angel syndicate; initial and seed investment | Scottish ecosystem; investment-ready, innovative companies | Decision tool and short proposal |
| Eos | Science and technology investment; seed and growth | Scottish roots; current criteria prefer Scottish headquarters | Official contact route |
| TRICAPITAL Angels | Angel syndicate; differentiated early and growth businesses | Scottish economic impact and published eligibility criteria | Apply for Funding |
| Kelvin Capital | Angel syndicate; revenue or near-revenue | UK-based, strong IP and commercial pipeline | Dealum application |
| Epidarex | Life-science VC; seed and Series A | US and UK research hubs; scientific and commercial criteria | Business-plan submission |
| PXN Ventures | Venture investment; pre-seed to Series B+ across programmes | Scotland, Northern England and Northern Ireland; fund-specific fit | Pitch to us |
| Maven, IFS equity finance | Regional equity; startups and growing businesses | Material Scottish operations or plans for them | IFS application |
| Scottish Enterprise | Public equity co-investment | Scottish growth criteria plus qualifying private-investor support | Relevant partner or lead, then enquiry |
| Scottish National Investment Bank | Development capital; debt or equity | Scottish connection and mission fit; typically more than £1m support | Investment enquiry |
| Scottish Equity Partners | Enterprise-technology growth investment | European heritage, proven deployments and strong underlying economics | Official contact route |
| Playfair | VC; exclusively pre-seed | UK and Europe; wider eligibility, not a Scottish-office claim | Pitch Us |
Choose your first five conversations
Start with a company-specific filter rather than contacting all 16 providers. Write down where the business is registered, where the team operates, the evidence you already have and what the next round will fund.
- Before seed: Research Gabriel, Techstart, Investing Women Angels and Playfair against their exact criteria. University-origin teams can also investigate Old College Capital.
- Science and defensible IP: Compare Archangels, Eos and Epidarex. Their technology and development requirements differ; “life sciences” is not one uniform mandate.
- Commercial evidence in place: Review Kelvin, relevant PXN programmes and Maven’s Scottish equity route. Do not treat all three as interchangeable.
- A private lead already engaged: Investigate the applicable Scottish Enterprise co-investment route. Record what the private investor must do next.
- An established enterprise business or substantial project: Compare SEP or the Bank’s specific criteria. Neither should be treated as a default idea-stage investor.
These are starting filters, not personalised funding recommendations. A good shortlist records the evidence for fit and the unresolved question for each provider.
First cheques and university-linked capital
Gabriel Investment Syndicate
Gabriel explicitly focuses on pre-seed companies where specialist knowledge or patentable technology creates an advantage. Its funding page distinguishes its usual early opportunity from larger co-investments where lead discussions are advanced. Prepare a concise explanation of your technical edge, Scottish base and next commercial milestone.
Techstart Ventures
Techstart describes an inception-to-pre-seed approach across Scotland and Northern Ireland. It can lead, co-lead or selectively co-invest. Its investment page provides a Scotland-specific submission route and welcomes cold inbound, making it worth researching even without a mutual connection.
Old College Capital
Old College Capital manages the University of Edinburgh’s early-stage investments and supports ideas emerging from the University. It describes pre-seed through Series A investment. Your relevant university relationship belongs near the top of an enquiry; simply operating in Edinburgh is not the same qualification.
Investing Women Angels
Investing Women Angels considers UK companies with at least one female founder at pre-seed and seed. Applications go through its linked Dealum portal. Review the current investment criteria and published fee arrangements, and distinguish applying for investment from joining an investor or founder-education programme.
Playfair
Playfair is a wider UK and European pre-seed route, not an Edinburgh or Glasgow office listing. Its published process separates early conversations, diligence, founder committee and internal committee. Ask how your company fits the mandate and what information would unlock the next decision.
Scottish angels and science investors
Archangels
Archangels requires companies to be both registered and operationally based in Scotland. Its criteria cover B2B technology and life sciences, defensible IP and stages from proof of concept through expansion. The syndicate describes a lead-investor role, but board approval and individual-member book-building are separate steps.
Equity Gap
Equity Gap’s members invest at initial or seed stage and may join larger rounds with others. The funding page asks for a short proposal after an investment-readiness check. Use that format to show market demand, your team and the proposed use of capital rather than sending an unfocused document bundle.
Eos
Eos invests in science and technology spanning healthcare and environmental sustainability. Its official criteria prefer Scottish headquarters, protectable IP and a commercial strategy. Although it works with family offices, that does not make every Eos opportunity a direct family-office investment. Describe both the scientific evidence and the path to commercial value.
TRICAPITAL Angels
TRICAPITAL covers several growth sectors and seeks businesses with meaningful Scottish economic impact. Its process page explains that members make the investments individually. Screening, member presentation and book-building all matter. Check its current eligibility rules and fees before treating an expression of interest as round capacity.
Kelvin Capital
Kelvin’s published criteria require a UK-based business with strong IP that is generating revenue or close to it, with a commercial pipeline. This is a useful boundary for founders: a promising prototype alone may not match. Its linked application is the place to show the connection between the product, customers and financing plan.
Epidarex
Epidarex builds life-science companies around US and UK research, including seed and Series A formation investment. Its criteria address scientific differentiation, IP, development and commercial evidence. A biomedical team should describe its specific programme and milestones, rather than infer eligibility from the broad label “healthcare.”
Venture, growth and public co-investment
PXN Ventures
Par Equity and Praetura combined as PXN, so this guide counts the group once. PXN Ventures spans pre-seed to Series B+ across its programmes and serves Scotland and the wider North. Identify the relevant programme instead of assuming that every team or vehicle has the same stage mandate.
Maven’s Investment Fund for Scotland equity route
Maven’s IFS equity programme explicitly covers Greater Edinburgh and Greater Glasgow. It supports startups and established growth businesses with material Scottish activity or plans to establish it. This entry concerns that regional equity route, not every Maven strategy. Its public application asks for a business plan and financial projections.
Scottish Enterprise
Scottish Enterprise’s equity funds invest alongside private investors. The Co-investment Fund requires an accredited partner; the Venture Fund requires an experienced private lead’s funding offer. Review the current strategy as well. Public equity is not a substitute for assembling the required private-investor support.
Scottish National Investment Bank
The Bank considers businesses connected to Scotland or seeking to move there, aligned with its missions. It typically considers more than £1m in debt or equity support. Record which financing instrument fits your project: this is investment on commercial terms, not a grant or an automatic small startup cheque.
Scottish Equity Partners
SEP’s current focus is enterprise technology with proven deployments, growth and strong underlying economics. It is a growth-stage comparison point, not a generic pre-seed option. An established team should prepare evidence of adoption and account expansion; an idea-stage founder should prioritise a more suitable route.
Does it matter whether you are in Edinburgh or Glasgow?
It matters to the relationships and evidence you can build, but the provider’s mandate is the deciding factor. Edinburgh university-origin founders have a clearly defined route through Old College Capital. Scottish angel and regional funds may consider companies across both cities and beyond. Maven explicitly lists both metropolitan areas.
Separate four fields in your research: investor office, your operating base, legal domicile and investment eligibility. They are not synonyms. If you are considering relocation, ask the provider what must be true before applying, at investment and after closing. Do not change company structure based on a directory alone.
Your Scottish investor shortlist worksheet
| Field | What to record | Example question |
|---|---|---|
| Stage and evidence | Current product, revenue and development milestone | Do you invest before our next milestone or only after it? |
| Scottish connection | Registration, operations and university relationship | Which connection is required for this specific fund? |
| Role in round | Lead, co-lead, participant or public co-investor | What other investor needs to be in place? |
| Approach route | Official form, enquiry or existing relationship | What should the first submission contain? |
| Decision and next action | Named owner, open question and agreed follow-up | Who makes the next decision, and what evidence do they need? |
Choose five genuinely plausible providers, write one specific fit sentence for each, and resolve the biggest eligibility uncertainty before expanding the list. Track contacts, relationship context and follow-up in Finta so the work becomes an active pipeline rather than another research document.
A copyable Aurora shortlist prompt
Help me review a Scottish startup investor shortlist.
Company: [stage, sector, product evidence and revenue status]
Location: [registration, operating base and university relationship]
Round: [amount, milestone and existing investor discussions]
Providers and official source links: [paste]
For each provider, separate documented fit, exclusions and unknowns.
Distinguish office location from company eligibility, and lead from co-investor.
Count rebrands and related funds once. Do not invent mandates or introductions.
Return five priority research conversations, one question for each, and a next-action owner.
Do not contact anyone or submit an application.
Methodology and next reading
Finta Editorial Team reviewed the linked official criteria and approach pages on November 12, 2026. Each provider is counted once; affiliated programmes, the PXN predecessor brands and Scottish Enterprise’s two equity funds are not additional investors. Angel syndicates represent member investment, while public development and co-investment capital are labelled separately. Programmes that do not invest are not counted. Stages and routes can change; confirm them with the provider before applying.
For the broader process, use the pre-seed fundraising guide, Seed Fundraising Comprehensive Guide and fundraising pipeline review. This article provides general research information, not investment, legal or tax advice.
